FindTrial
Sign In

Pharmacogenomics of Hematologic Neoplasms chemotherapy

Pharmacogenomics of Hematologic Neoplasms chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RNC-12002959
Enrollment
Unknown
Registered
2012-12-31
Start date
2008-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Neoplasms

Interventions

no:no

Sponsors

Institution of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 85 Years

Inclusion criteria

Inclusion criteria: Hematologic Neoplasms patients

Exclusion criteria

Exclusion criteria: non-Hematologic Neoplasms patients

Design outcomes

Primary

MeasureTime frame
bone marrow slides;—

Countries

China

Contacts

Public ContactZhaoqian Liu
liuzhaoqian63@126.com+86 13787797720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026